Suppr超能文献

相似文献

1
Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C.
Proc Natl Acad Sci U S A. 2007 Apr 3;104(14):6025-30. doi: 10.1073/pnas.0607026104. Epub 2007 Mar 28.
4
Discordant role of CD4 T-cell response relative to neutralizing antibody and CD8 T-cell responses in acute hepatitis C.
Gastroenterology. 2007 Feb;132(2):654-66. doi: 10.1053/j.gastro.2006.11.044. Epub 2006 Nov 29.
5
Role of the E2 Hypervariable Region (HVR1) in the Immunogenicity of a Recombinant Hepatitis C Virus Vaccine.
J Virol. 2018 May 14;92(11). doi: 10.1128/JVI.02141-17. Print 2018 Jun 1.
7
The hepatitis C virus glycan shield and evasion of the humoral immune response.
Viruses. 2011 Oct;3(10):1909-32. doi: 10.3390/v3101909. Epub 2011 Oct 14.
8
Hepatitis C virus continuously escapes from neutralizing antibody and T-cell responses during chronic infection in vivo.
Gastroenterology. 2007 Feb;132(2):667-78. doi: 10.1053/j.gastro.2006.12.008. Epub 2006 Dec 3.
9
Selection pressure from neutralizing antibodies drives sequence evolution during acute infection with hepatitis C virus.
Gastroenterology. 2009 Jun;136(7):2377-86. doi: 10.1053/j.gastro.2009.02.080. Epub 2009 Mar 17.

引用本文的文献

1
Targets of protective immunity and opportunities in hepatitis C virus vaccine development.
Nat Rev Immunol. 2025 Sep 12. doi: 10.1038/s41577-025-01215-9.
3
CD4 T cells and B cell help - when exhausted cells can still function.
JHEP Rep. 2025 Apr 23;7(7):101435. doi: 10.1016/j.jhepr.2025.101435. eCollection 2025 Jul.
5
Bispecific antibodies against the hepatitis C virus E1E2 envelope glycoprotein.
Proc Natl Acad Sci U S A. 2025 Apr 15;122(15):e2420402122. doi: 10.1073/pnas.2420402122. Epub 2025 Apr 7.
6
Hepatitis C Virus-Pediatric and Adult Perspectives in the Current Decade.
Pathogens. 2024 Dec 29;14(1):11. doi: 10.3390/pathogens14010011.
8
Viral Hepatitis: Host Immune Interaction, Pathogenesis and New Therapeutic Strategies.
Pathogens. 2024 Sep 5;13(9):766. doi: 10.3390/pathogens13090766.
9
Update on Hepatitis C Vaccine: Results and Challenges.
Viruses. 2024 Aug 21;16(8):1337. doi: 10.3390/v16081337.

本文引用的文献

1
Hepatitis C virus entry: molecular biology and clinical implications.
Hepatology. 2006 Sep;44(3):527-35. doi: 10.1002/hep.21321.
2
Viral and cellular determinants of the hepatitis C virus envelope-heparan sulfate interaction.
J Virol. 2006 Nov;80(21):10579-90. doi: 10.1128/JVI.00941-06. Epub 2006 Aug 23.
3
Host cell responses induced by hepatitis C virus binding.
Hepatology. 2006 Jun;43(6):1326-36. doi: 10.1002/hep.21191.
5
Antiviral antibody responses: the two extremes of a wide spectrum.
Nat Rev Immunol. 2006 Mar;6(3):231-43. doi: 10.1038/nri1783.
6
Production of infectious hepatitis C virus in tissue culture: a breakthrough for basic and applied research.
J Hepatol. 2006 Feb;44(2):436-9. doi: 10.1016/j.jhep.2005.11.031. Epub 2005 Dec 5.
8
Adaptive immune responses in acute and chronic hepatitis C virus infection.
Nature. 2005 Aug 18;436(7053):946-52. doi: 10.1038/nature04079.
9
Unscrambling hepatitis C virus-host interactions.
Nature. 2005 Aug 18;436(7053):930-2. doi: 10.1038/nature04076.
10
Monoclonal antibody AP33 defines a broadly neutralizing epitope on the hepatitis C virus E2 envelope glycoprotein.
J Virol. 2005 Sep;79(17):11095-104. doi: 10.1128/JVI.79.17.11095-11104.2005.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验